The Bio Report
By Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Episodes (2)
The Bio Report
Stopping Shape-Shifting Tumors with a First-in-Class Epigenetic Drug
K36 Therapeutics is pioneering a first-in-class epigenetic drug targeting NSD2, a key driver in aggressive, treatment-resistant cancers like neuroendocrine prostate cancer and multiple myeloma. The company’s lead compound, K36-1001, is in clinical trials for m
The Bio Report
Building a Genetics Engine to Crack the Target Bottleneck
Regeneron's Regeneron Genetics Center (RGC) is leveraging unprecedented scale and AI-driven analytics to transform drug discovery, with a focus on human genetics as a primary success driver. The guest, Aris Barris, reveals that RGC has moved from sequencing hu
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime